This is a request for five additional years support to carry out
experiments involving metabolic subcellular changes in the liver and how
they influence the onset of meals in rats. Prior evidence produced by the
investigator suggests that when food intake is initiated after the
administration of the metabolic inhibitor, 2, 5-AM, there are several
correlates in hepatocytes that may well have a causal role. More
specifically, the results of several types of experiments have converged
to strongly implicate that the liver is the target for 2, 5-AMs or
exigenicaction; and other experiments have indicated that a key factor (or
at least close correlate) is a reduction in the amount of ATP in
hepatocytes. Proposed experiments will take the analysis to a more
reductionistic level by assessing whether bound or free cellular ATP is
more correlated with eating and by then determining if a reduction in the
key ATP pool elicit seating when induced by other means; will determine if
other drugs thought to elicit eating via the liver (e.g., methyl
palmoxirate) are associated with similar hepatocyte changes; will assess
the hypothesis that the signal to eat is associated with functioning of
the hepatocyte sodium pump; and will determine if changes in hepatocyte
calcium pools are a means for generating a signal that could pass from
hepatocytes to other cells and on the CNS.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
adenosine triphosphateantimetabolitesbehavior predictionbioenergeticscalcium fluxcarbohydrate analoglaboratory ratliver cellsliver metabolismmannitolnuclear magnetic resonance spectroscopynutrient intake activitynutrition related tagouabainpsychobiologysodium potassium exchanging ATPase
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
848
DUNS Number
088812565
UEI
DJCTQA1PR7Q4
Project Start Date
01-August-1993
Project End Date
30-November-2001
Budget Start Date
05-December-1998
Budget End Date
30-November-1999
Project Funding Information for 1999
Total Funding
$266,308
Direct Costs
$192,726
Indirect Costs
$73,582
Year
Funding IC
FY Total Cost by IC
1999
National Institute of Diabetes and Digestive and Kidney Diseases
$266,308
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK053109-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK053109-06
Patents
No Patents information available for 5R01DK053109-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK053109-06
Clinical Studies
No Clinical Studies information available for 5R01DK053109-06
News and More
Related News Releases
No news release information available for 5R01DK053109-06
History
No Historical information available for 5R01DK053109-06
Similar Projects
No Similar Projects information available for 5R01DK053109-06